Thema
Journal Article
11
Clinical Trial, Phase II
5
Antineoplastic Agents
4
EWS–FLI1
4
Ewing sarcoma
4
Mithramycin
4
Antibodies, Monoclonal
3
Research Support, N.I.H., Extramural
3
Review
3
ATM
2
ATR
2
Antibodies, Monoclonal, Humanized
2
BRCA wild type
2
BRCAwt
2
CHK1
2
CHK2
2
Clinical Trial, Phase I
2
DNA damage repair
2
DNA repair deficiencies
2
DNA-PKcs
2
EC 1.3.99.1
2
EC 2.7.10.1
2
Enzyme Inhibitors
2
Homologous recombination
2
PARP
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Research Support, N.I.H., Intramural
2
Research Support, Non-U.S. Gov't
2
Succinate Dehydrogenase
2
biomarkers
2
cell cycle
2
high grade serous ovarian cancer
2
immune checkpoint inhibitors
2
136601-57-5
1
2KT4YN1DP7
1
67763-96-6
1
67763-97-7
1
82115-62-6
1
83869-56-1
1
Antibiotics, Antineoplastic
1
Antineoplastic Agents, Immunological
1
B7 Antigens
1
BRCA1 Protein
1
BRCA1 protein, human
1
BRCA2 Protein
1
BRCA2 protein, human
1
Biological Products
1
CCND1 protein, human
1
CD276 protein, human
1
Cyclin D1
1
mehr ...